Moo Rim Kang

927 total citations
26 papers, 754 citations indexed

About

Moo Rim Kang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Moo Rim Kang has authored 26 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Moo Rim Kang's work include RNA Interference and Gene Delivery (6 papers), RNA modifications and cancer (6 papers) and RNA Research and Splicing (4 papers). Moo Rim Kang is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), RNA modifications and cancer (6 papers) and RNA Research and Splicing (4 papers). Moo Rim Kang collaborates with scholars based in South Korea, United States and China. Moo Rim Kang's co-authors include Jong Soon Kang, Sang‐Bae Han, Glen Yang, Robert F. Place, Jieun Yun, Song‐Kyu Park, Long‐Cheng Li, Chang Woo Lee, Myeong Youl Lee and Muthiah Manoharan and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Moo Rim Kang

26 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moo Rim Kang South Korea 15 476 243 92 77 71 26 754
Chun-Chung Lee Taiwan 16 525 1.1× 223 0.9× 116 1.3× 71 0.9× 158 2.2× 20 907
Chuangyu Wen China 18 506 1.1× 279 1.1× 52 0.6× 37 0.5× 113 1.6× 34 752
Yuta Suzuki Japan 17 338 0.7× 253 1.0× 165 1.8× 54 0.7× 124 1.7× 49 761
Jia‐Sin Yang Taiwan 17 557 1.2× 241 1.0× 77 0.8× 48 0.6× 165 2.3× 30 855
Ruifen Sun China 18 469 1.0× 378 1.6× 60 0.7× 51 0.7× 80 1.1× 35 740
Hwan‐Mook Kim South Korea 19 502 1.1× 194 0.8× 131 1.4× 34 0.4× 93 1.3× 43 897
Heran Wang China 11 388 0.8× 179 0.7× 44 0.5× 55 0.7× 187 2.6× 24 686
Dong‐Chan Park South Korea 11 357 0.8× 168 0.7× 62 0.7× 38 0.5× 51 0.7× 20 781
Pei Xiao China 14 564 1.2× 293 1.2× 56 0.6× 138 1.8× 128 1.8× 32 993

Countries citing papers authored by Moo Rim Kang

Since Specialization
Citations

This map shows the geographic impact of Moo Rim Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moo Rim Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moo Rim Kang more than expected).

Fields of papers citing papers by Moo Rim Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moo Rim Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moo Rim Kang. The network helps show where Moo Rim Kang may publish in the future.

Co-authorship network of co-authors of Moo Rim Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Moo Rim Kang. A scholar is included among the top collaborators of Moo Rim Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moo Rim Kang. Moo Rim Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Moo Rim, Ki Hwan Park, Chang Woo Lee, et al.. (2018). Small activating RNA induced expression of VHL gene in renal cell carcinoma. The International Journal of Biochemistry & Cell Biology. 97. 36–42. 14 indexed citations
2.
Kang, Moo Rim, et al.. (2017). Development of Therapeutic dsP21-322 for Cancer Treatment. Advances in experimental medicine and biology. 983. 217–229. 6 indexed citations
3.
Kang, Moo Rim, Ki Hwan Park, Chang Woo Lee, et al.. (2016). miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells. PLoS ONE. 11(8). e0160961–e0160961. 39 indexed citations
4.
Park, Ki Hwan, Yeo Dae Yoon, Moo Rim Kang, et al.. (2015). Hypothemycin inhibits tumor necrosis factor-α production by tristetraprolin-dependent down-regulation of mRNA stability in lipopolysaccharide-stimulated macrophages. International Immunopharmacology. 29(2). 863–868. 4 indexed citations
5.
Kang, Moo Rim, Ki Hwan Park, Soo Jin Oh, et al.. (2015). Cardiovascular protective effect of glabridin: Implications in LDL oxidation and inflammation. International Immunopharmacology. 29(2). 914–918. 44 indexed citations
6.
Lee, Chang Woo, Moo Rim Kang, Jieun Yun, Soo Jin Oh, & Jong Soon Kang. (2014). Abstract 4387: Up-regulation of VHL by miR-1273C inhibits renal cell carcinoma. Cancer Research. 74(19_Supplement). 4387–4387. 1 indexed citations
7.
Ren, Shancheng, Moo Rim Kang, Ji Wang, et al.. (2013). Targeted induction of endogenous NKX3‐1 by small activating RNA inhibits prostate tumor growth. The Prostate. 73(14). 1591–1601. 33 indexed citations
8.
Lee, Chang Woo, Myeong Youl Lee, Moo Rim Kang, et al.. (2013). Differential anti-inflammatory and analgesic effects by enantiomers of zaltoprofen in rodents. International Immunopharmacology. 16(4). 457–460. 9 indexed citations
9.
Kang, Moo Rim, Glen Yang, Robert F. Place, et al.. (2012). Intravesical Delivery of Small Activating RNA Formulated into Lipid Nanoparticles Inhibits Orthotopic Bladder Tumor Growth. Cancer Research. 72(19). 5069–5079. 87 indexed citations
10.
Kang, Moo Rim, et al.. (2012). Targeted p21 WAF1/CIP1 Activation by RNAa Inhibits Hepatocellular Carcinoma Cells. Nucleic Acid Therapeutics. 22(5). 335–343. 35 indexed citations
11.
Cho, Gyunggoo, Youngkyu Song, Jong Soon Kang, et al.. (2012). Is apparent diffusion coefficient reliable and accurate for monitoring effects of antiangiogenic treatment in a longitudinal study?. Journal of Magnetic Resonance Imaging. 35(6). 1430–1436. 6 indexed citations
12.
Kang, Moo Rim, Glen Yang, Klaus Charissé, et al.. (2012). An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment. Journal of Visualized Experiments. 11 indexed citations
13.
Kang, Moo Rim, Jong Soon Kang, Jin-Ah Kim, et al.. (2011). Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines. Oncology Letters. 3(1). 113–118. 12 indexed citations
14.
Kang, Moo Rim, Hwan Mook Kim, Jong Soon Kang, et al.. (2011). Lipid-Soluble Ginseng Extract Induces Apoptosis and G0/G1 Cell Cycle Arrest in NCI-H460 Human Lung Cancer Cells. Plant Foods for Human Nutrition. 66(2). 101–106. 16 indexed citations
15.
Park, Song‐Kyu, Eun Sil Lee, Hwan Mook Kim, et al.. (2010). A Lipid-Soluble Red Ginseng Extract Inhibits the Growth of Human Lung Tumor Xenografts in Nude Mice. Journal of Medicinal Food. 13(1). 1–5. 68 indexed citations
16.
Lee, Kyeong, Song‐Kyu Park, Yinglan Jin, et al.. (2010). LW6, a novel HIF-1 inhibitor, promotes proteasomal degradation of HIF-1α via upregulation of VHL in a colon cancer cell line. Biochemical Pharmacology. 80(7). 982–989. 126 indexed citations
17.
Kang, Moo Rim, Kiho Lee, Jong Soon Kang, et al.. (2010). KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein.. PubMed. 23(3). 801–9. 7 indexed citations
18.
Cho, Jee‐Hyun, Gyunggoo Cho, Youngkyu Song, et al.. (2010). Feasibility of FAIR imaging for evaluating tumor perfusion. Journal of Magnetic Resonance Imaging. 32(3). 738–744. 8 indexed citations
19.
20.
Kang, Moo Rim, Jong Soon Kang, Sang‐Bae Han, et al.. (2009). A novel δ-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells. Biochemical Pharmacology. 78(5). 486–494. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun-Chung Lee Breakdown of academic impact, for papers by Chuangyu Wen Breakdown of academic impact, for papers by Yuta Suzuki Breakdown of academic impact, for papers by Jia‐Sin Yang Breakdown of academic impact, for papers by Ruifen Sun Breakdown of academic impact, for papers by Hwan‐Mook Kim Breakdown of academic impact, for papers by Heran Wang Breakdown of academic impact, for papers by Dong‐Chan Park Breakdown of academic impact, for papers by Pei Xiao
Rankless by CCL
2026